1 week Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing Yahoo Finance

   X     

2 weeks Vertex Pharmaceuticals price target raised to $520 from $460 at Truist Yahoo Finance

   X     

2 weeks Calls of the Day: Charles Schwab, Vertex Pharma and Transocean YouTube

   X     

2 weeks VRTX’s Q4 Earnings Miss Mark, Revenues Beat on Higher Product Sales Zacks

   X     

2 weeks Vertex Posts ‘Another Impressive Quarterly Revenue Beat.’ But The Future Remains Uncertain. Investor's Business Daily

   X     

2 weeks Vertex Pharmaceuticals Incorporated (VRTX) Q4 2024 Earnings Call Transcript Seeking Alpha

   X     

2 weeks Vertex Pharmaceuticals Incorporated 2024 Q4 – Results – Earnings Call Presentation Seeking Alpha

   X     

2 weeks Vertex Pharmaceuticals (VRTX) Misses Q4 Earnings Estimates Zacks

   X     

2 weeks Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand Investing.com

   X     

2 weeks Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand Yahoo Finance

   X     

2 weeks Vertex earnings missed by $0.04, revenue topped estimates Investing.com

   X     

2 weeks Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj YouTube

   X     

3 weeks Final Trades: Energy Transfer, Vertex Pharma, UnitedHealth and Axon Enterprise YouTube

   X     

3 weeks Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval Zacks

   X     

3 weeks Unlocking Q4 Potential of Vertex (VRTX): Exploring Wall Street Estimates for Key Metrics Zacks

   X     

3 weeks Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note Zacks

   X     

3 weeks Vertex: Maintaining Buy Despite Tempered Expectations For Journavx In Pain Seeking Alpha

   X     

3 weeks Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank Yahoo Finance

   X     

3 weeks Vertex: YOY Decline In Q4 Earnings Expected, But Revenue Continues To Shine Seeking Alpha

   X     

3 weeks Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug Seeking Alpha

   X     

3 weeks How Painkillers Could Be Vertex Pharmaceuticals’ Next $10 Billion Chapter Investor's Business Daily

   X     

3 weeks These Stocks Moved the Most Today: Apple, Intel, Chevron, Exxon, Walgreens, AbbVie, Deckers, Atlassian, Vertex, and More Yahoo Finance

   X     

3 weeks VRTX Gets FDA Nod for Non-Opioid Pain Drug Journavx, Shares Up Zacks

   X     

3 weeks Vertex Pharmaceuticals CEO on non-opioid painkiller: It’s safe, effective and non-addictive YouTube

   X     

3 weeks FDA approves non-opioid painkiller designed to eliminate risk of addiction Fast Company

   X     

3 weeks Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment. MarketWatch

   X     

3 weeks Vertex Pharma shares jump on FDA approval for its non-opioid painkiller Investing.com

   X     

3 weeks Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller Investor's Business Daily

   X     

3 weeks Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug Yahoo Finance

   X     

3 weeks FDA approves Vertex’s first-in-class non-opioid analgesic for acute pain Investing.com

   X     

4 weeks Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

   X     

4 weeks Vertex (VERX) Upgraded to Strong Buy: Here’s Why Zacks

   X     

4 weeks Earnings Preview: Vertex Pharmaceuticals (VRTX) Q4 Earnings Expected to Decline Zacks

   X     

1 month Vertex Down 13% in 6 Months: Buy, Sell or Hold the Stock? Zacks

   X     

1 month Vertex, Inc. (VERX) Hits Fresh High: Is There Still Room to Run? Zacks

   X     

1 month Vertex Pharmaceuticals (VRTX) Advances But Underperforms Market: Key Facts Zacks

   X     

1 month Vertex: Risky Valuation Amid Shaky Organic Growth Seeking Alpha

   X     

1 month Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know Zacks

   X     

1 month Vertex Therapeutics: The Pain Comes With The Territory For Suzetrigine Seeking Alpha

   X     

1 month Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Hosts 43rd Annual J.P. Morgan Healthcare Conference (Transcript) Seeking Alpha

   X     

1 month Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement Yahoo Finance

   X     

1 month Vertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You Should Know Zacks

   X     

1 month INCY vs. VRTX: Which Stock Is the Better Value Option? Zacks

   X     

2 months Here’s Why You Should Add Vertex Stock to Your Portfolio Now Zacks

   X     

2 months Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note Zacks

   X     

2 months Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

2 months Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors Zacks

   X     

2 months Vertex Pharmaceuticals: Jim Cramer Fires A Warning Shot But I Remain Invested Seeking Alpha

   X     

2 months Is the Options Market Predicting a Spike in Vertex Pharmaceuticals (VRTX) Stock? Zacks

   X     

2 months Stocks Hold In Quiet Day; Burlington Stores, Boston Scientific, Vertex Inc. In Focus Yahoo Finance

   X